|
First author, year | Age (sex) | Chemotherapeutic agent | Cancer | Associated symptoms | Weight loss (kg) | Imaging | Treatment |
|
Ushiki, 2012 [9] | 61 (M) | Cisplatin | Squamous cell carcinoma, lung | Anorexia, nausea, vomiting | 7 | CT abdomen, upper GI series, abdominal X-ray | Tubal feeding; weight gain |
Chowdhary, 2015 [10] | 81 (M) | Carboplatin | Mesothelioma | Epigastric pain, nausea, vomiting | 18 | CT abdomen, upper GI series, esophagogram | Conservative; weight gain |
Irei, 2016 [11] | ∼60 s (M) | Neo-adjuvant chemotherapy | Esophageal | Postprandial abdominal pain | 6 | CT and upper GI series | Roux-en-Y bypass of gastrostomy and jejunostomy |
Lippl, 2002 [12] | 31 (M) | Palliative chemotherapy | Colorectal cancer | Recurrent vomiting | 7 | CT abdomen, digital fluoroscopy, esophagogastroduodenoscopy | Parenteral nutrition; weight gain |
Bang, 2009 [13] | 57 (F) | Palliative chemotherapy | Colon cancer with peritoneal seeding | Post-prandial abdominal pain, nausea | 6 | CT abdomen and small bowel series | Adhesiolysis and duodenojejunostomy |
Girotra, 2013 [14] | 60 (F) | Chemotherapy | Breast cancer | Post-prandial pain, vomiting, nausea | 36 | CT abdomen, barium swallow, esophagogastroduodenoscopy | Conservative; weight gain |
|